25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Cipher Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyze Cipher Pharmaceuticals Inc together

I guess you are interested in Cipher Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cipher Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Cipher Pharmaceuticals Inc

I send you an email if I find something interesting about Cipher Pharmaceuticals Inc.

1. Quick Overview

1.1. Quick analysis of Cipher Pharmaceuticals Inc (30 sec.)










1.2. What can you expect buying and holding a share of Cipher Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$3.47
Expected worth in 1 year
$4.21
How sure are you?
75.0%

+ What do you gain per year?

Total Gains per Share
$0.74
Return On Investment
7.2%

For what price can you sell your share?

Current Price per Share
$10.25
Expected price per share
$7.45 - $14.60
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Cipher Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)
$10.25
Intrinsic Value Per Share
$4.33 - $11.52
Total Value Per Share
$7.80 - $14.99

2.2. Growth of Cipher Pharmaceuticals Inc (5 min.)




Is Cipher Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$88.7m$61.4m$21.6m26.0%

How much money is Cipher Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money$5.6m$7m-$1.3m-24.0%
Net Profit Margin103.0%142.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Cipher Pharmaceuticals Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Cipher Pharmaceuticals Inc?

Welcome investor! Cipher Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Cipher Pharmaceuticals Inc.

First you should know what it really means to hold a share of Cipher Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Cipher Pharmaceuticals Inc is $10.25. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cipher Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cipher Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.47. Based on the TTM, the Book Value Change Per Share is $0.19 per quarter. Based on the YOY, the Book Value Change Per Share is $0.28 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cipher Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.121.1%0.222.2%0.282.7%0.141.3%0.080.8%
Usd Book Value Change Per Share0.131.2%0.191.8%0.282.7%0.121.2%0.040.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.131.2%0.191.8%0.282.7%0.121.2%0.040.4%
Usd Price Per Share6.05-5.00-2.57-2.22-3.38-
Price to Earnings Ratio12.92-6.97-4.31-5.18-6.95-
Price-to-Total Gains Ratio48.35-31.27-17.27-23.67-35.48-
Price to Book Ratio1.74-1.52-1.09-1.07-2.26-
Price-to-Total Gains Ratio48.35-31.27-17.27-23.67-35.48-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share10.25
Number of shares97
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.190.12
Usd Total Gains Per Share0.190.12
Gains per Quarter (97 shares)17.9711.99
Gains per Year (97 shares)71.8747.97
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10726204838
2014413409686
302162060144134
402872780192182
503593500240230
604314220288278
705034940336326
805755660384374
906476380432422
1007197100480470

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%33.07.00.082.5%48.033.00.059.3%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%30.010.00.075.0%49.032.00.060.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%3.00.078.03.7%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%30.010.00.075.0%49.032.00.060.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Cipher Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1250.185-32%0.278-55%0.124+1%0.042+197%
Book Value Per Share--3.4703.245+7%2.398+45%1.890+84%1.594+118%
Current Ratio--11.1848.102+38%3.945+184%3.540+216%3.000+273%
Debt To Asset Ratio--0.0540.084-35%0.154-65%0.224-76%0.376-86%
Debt To Equity Ratio--0.0580.094-39%0.185-69%0.314-82%0.872-93%
Dividend Per Share----0%-0%-0%-0%
Eps--0.1170.221-47%0.278-58%0.135-14%0.084+40%
Free Cash Flow Per Share--0.2430.165+47%0.126+92%0.122+100%0.107+127%
Free Cash Flow To Equity Per Share--0.2430.115+111%0.119+104%0.076+219%0.082+196%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.166-14%
Intrinsic Value_10Y_max--11.517--------
Intrinsic Value_10Y_min--4.334--------
Intrinsic Value_1Y_max--0.625--------
Intrinsic Value_1Y_min--0.431--------
Intrinsic Value_3Y_max--2.280--------
Intrinsic Value_3Y_min--1.305--------
Intrinsic Value_5Y_max--4.422--------
Intrinsic Value_5Y_min--2.185--------
Market Cap262292375.000+41%154816475.000128098675.710+21%65727235.350+136%57535442.485+169%89171609.695+74%
Net Profit Margin--0.5651.030-45%1.420-60%0.648-13%0.288+96%
Operating Margin---0.142-100%0.452-100%0.457-100%0.393-100%
Operating Ratio--0.7200.648+11%0.525+37%0.498+45%0.628+15%
Pb Ratio2.954+41%1.7441.525+14%1.092+60%1.070+63%2.261-23%
Pe Ratio21.894+41%12.9236.973+85%4.313+200%5.179+150%6.953+86%
Price Per Share10.250+41%6.0505.003+21%2.565+136%2.215+173%3.375+79%
Price To Free Cash Flow Ratio10.552+41%6.2299.703-36%6.312-1%5.558+12%16.658-63%
Price To Total Gains Ratio81.915+41%48.35031.268+55%17.273+180%23.666+104%35.478+36%
Quick Ratio--0.7681.706-55%3.680-79%2.117-64%2.211-65%
Return On Assets--0.0320.063-49%0.096-67%0.050-36%0.022+47%
Return On Equity--0.0340.069-51%0.112-70%0.061-44%0.005+525%
Total Gains Per Share--0.1250.185-32%0.278-55%0.124+1%0.042+197%
Usd Book Value--88796000.00083114500.000+7%61466750.000+44%49340750.000+80%41956797.913+112%
Usd Book Value Change Per Share--0.1250.185-32%0.278-55%0.124+1%0.042+197%
Usd Book Value Per Share--3.4703.245+7%2.398+45%1.890+84%1.594+118%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.1170.221-47%0.278-58%0.135-14%0.084+40%
Usd Free Cash Flow--6214000.0004221500.000+47%3233500.000+92%3188000.000+95%2819075.955+120%
Usd Free Cash Flow Per Share--0.2430.165+47%0.126+92%0.122+100%0.107+127%
Usd Free Cash Flow To Equity Per Share--0.2430.115+111%0.119+104%0.076+219%0.082+196%
Usd Market Cap262292375.000+41%154816475.000128098675.710+21%65727235.350+136%57535442.485+169%89171609.695+74%
Usd Price Per Share10.250+41%6.0505.003+21%2.565+136%2.215+173%3.375+79%
Usd Profit--2995000.0005651000.000-47%7007750.000-57%3414150.000-12%1207235.327+148%
Usd Revenue--5304000.0005539750.000-4%4968750.000+7%5413550.000-2%6750008.737-21%
Usd Total Gains Per Share--0.1250.185-32%0.278-55%0.124+1%0.042+197%
 EOD+4 -4MRQTTM+16 -17YOY+17 -165Y+19 -1410Y+27 -7

3.3 Fundamental Score

Let's check the fundamental score of Cipher Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1521.894
Price to Book Ratio (EOD)Between0-12.954
Net Profit Margin (MRQ)Greater than00.565
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.768
Current Ratio (MRQ)Greater than111.184
Debt to Asset Ratio (MRQ)Less than10.054
Debt to Equity Ratio (MRQ)Less than10.058
Return on Equity (MRQ)Greater than0.150.034
Return on Assets (MRQ)Greater than0.050.032
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Cipher Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.069
Ma 20Greater thanMa 5010.356
Ma 50Greater thanMa 10011.105
Ma 100Greater thanMa 20010.439
OpenGreater thanClose10.590
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Cipher Pharmaceuticals Inc

Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome. The company's licensed products comprise Absorica, an oral retinoid indicated for the treatment of f severe nodular and/or inflammatory acne, acne conglobate and recalcitrant acne; Lipofen, which is indicated as adjunctive therapy to diet to reduce elevated LDL-C, total-C, triglycerides, and Apo B, and to increase HDL-C, as well as to reduce triglycerides in adult patients; and Conzip, an opioid agonist indicated for the management of moderate to moderately severe chronic pain in adults. Its pipeline products include MOB-015, a topical formulation of terbinafine, which is in phase 3 clinical trial for treatment of onychomycosis; CF-101 (Piclidenoson) that is in phase 3 clinical trial for severe plaque psoriasis and rheumatoid arthritis; and DTR-001, a tattoo removal cream, which is in pre-clinical stage. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Mississauga, Canada.

Fundamental data was last updated by Penke on 2024-11-15 11:13:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Cipher Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cipher Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 56.5% means that $0.56 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cipher Pharmaceuticals Inc:

  • The MRQ is 56.5%. The company is making a huge profit. +2
  • The TTM is 103.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ56.5%TTM103.0%-46.5%
TTM103.0%YOY142.0%-39.1%
TTM103.0%5Y64.8%+38.1%
5Y64.8%10Y28.8%+36.0%
4.3.1.2. Return on Assets

Shows how efficient Cipher Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cipher Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.2% Return on Assets means that Cipher Pharmaceuticals Inc generated $0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cipher Pharmaceuticals Inc:

  • The MRQ is 3.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 6.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ3.2%TTM6.3%-3.1%
TTM6.3%YOY9.6%-3.3%
TTM6.3%5Y5.0%+1.3%
5Y5.0%10Y2.2%+2.8%
4.3.1.3. Return on Equity

Shows how efficient Cipher Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cipher Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.4% Return on Equity means Cipher Pharmaceuticals Inc generated $0.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cipher Pharmaceuticals Inc:

  • The MRQ is 3.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 6.9%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.4%TTM6.9%-3.6%
TTM6.9%YOY11.2%-4.3%
TTM6.9%5Y6.1%+0.9%
5Y6.1%10Y0.5%+5.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Cipher Pharmaceuticals Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Cipher Pharmaceuticals Inc is operating .

  • Measures how much profit Cipher Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cipher Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cipher Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM14.2%-14.2%
TTM14.2%YOY45.2%-31.0%
TTM14.2%5Y45.7%-31.5%
5Y45.7%10Y39.3%+6.5%
4.3.2.2. Operating Ratio

Measures how efficient Cipher Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.72 means that the operating costs are $0.72 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cipher Pharmaceuticals Inc:

  • The MRQ is 0.720. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.648. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.720TTM0.648+0.072
TTM0.648YOY0.525+0.123
TTM0.6485Y0.498+0.151
5Y0.49810Y0.628-0.130
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Cipher Pharmaceuticals Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Cipher Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 11.18 means the company has $11.18 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cipher Pharmaceuticals Inc:

  • The MRQ is 11.184. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.102. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ11.184TTM8.102+3.083
TTM8.102YOY3.945+4.157
TTM8.1025Y3.540+4.562
5Y3.54010Y3.000+0.540
4.4.3.2. Quick Ratio

Measures if Cipher Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cipher Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.77 means the company can pay off $0.77 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cipher Pharmaceuticals Inc:

  • The MRQ is 0.768. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.706. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.768TTM1.706-0.937
TTM1.706YOY3.680-1.975
TTM1.7065Y2.117-0.411
5Y2.11710Y2.211-0.094
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Cipher Pharmaceuticals Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Cipher Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cipher Pharmaceuticals Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.05 means that Cipher Pharmaceuticals Inc assets are financed with 5.4% credit (debt) and the remaining percentage (100% - 5.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cipher Pharmaceuticals Inc:

  • The MRQ is 0.054. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.084. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.054TTM0.084-0.030
TTM0.084YOY0.154-0.069
TTM0.0845Y0.224-0.139
5Y0.22410Y0.376-0.153
4.5.4.2. Debt to Equity Ratio

Measures if Cipher Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cipher Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 5.8% means that company has $0.06 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cipher Pharmaceuticals Inc:

  • The MRQ is 0.058. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.094. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.058TTM0.094-0.036
TTM0.094YOY0.185-0.091
TTM0.0945Y0.314-0.221
5Y0.31410Y0.872-0.558
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cipher Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Cipher Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 12.92 means the investor is paying $12.92 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cipher Pharmaceuticals Inc:

  • The EOD is 21.894. Based on the earnings, the company is fair priced.
  • The MRQ is 12.923. Based on the earnings, the company is underpriced. +1
  • The TTM is 6.973. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD21.894MRQ12.923+8.971
MRQ12.923TTM6.973+5.949
TTM6.973YOY4.313+2.661
TTM6.9735Y5.179+1.795
5Y5.17910Y6.953-1.775
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cipher Pharmaceuticals Inc:

  • The EOD is 10.552. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 6.229. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 9.703. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD10.552MRQ6.229+4.324
MRQ6.229TTM9.703-3.474
TTM9.703YOY6.312+3.391
TTM9.7035Y5.558+4.145
5Y5.55810Y16.658-11.100
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Cipher Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Cipher Pharmaceuticals Inc:

  • The EOD is 2.954. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.744. Based on the equity, the company is underpriced. +1
  • The TTM is 1.525. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.954MRQ1.744+1.210
MRQ1.744TTM1.525+0.219
TTM1.525YOY1.092+0.433
TTM1.5255Y1.070+0.455
5Y1.07010Y2.261-1.191
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets93,910
Total Liabilities5,114
Total Stockholder Equity88,796
 As reported
Total Liabilities 5,114
Total Stockholder Equity+ 88,796
Total Assets = 93,910

Assets

Total Assets93,910
Total Current Assets54,959
Long-term Assets38,951
Total Current Assets
Cash And Cash Equivalents 47,984
Net Receivables 3,776
Inventory 2,898
Other Current Assets 301
Total Current Assets  (as reported)54,959
Total Current Assets  (calculated)54,959
+/-0
Long-term Assets
Property Plant Equipment 369
Goodwill 15,706
Intangible Assets 1,244
Long-term Assets  (as reported)38,951
Long-term Assets  (calculated)17,319
+/- 21,632

Liabilities & Shareholders' Equity

Total Current Liabilities4,914
Long-term Liabilities200
Total Stockholder Equity88,796
Total Current Liabilities
Total Current Liabilities  (as reported)4,914
Total Current Liabilities  (calculated)0
+/- 4,914
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt296
Long-term Liabilities  (as reported)200
Long-term Liabilities  (calculated)296
+/- 96
Total Stockholder Equity
Retained Earnings 74,025
Total Stockholder Equity (as reported)88,796
Total Stockholder Equity (calculated)74,025
+/- 14,771
Other
Capital Stock18,423
Common Stock Shares Outstanding 24,114
Net Invested Capital 88,796
Net Working Capital 50,045



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-09-302004-06-302004-03-31
> Total Assets 
33,219
31,393
31,150
31,581
28,378
24,619
22,140
27,694
24,526
22,240
19,309
17,707
17,780
20,105
18,901
17,177
15,742
16,277
13,457
11,940
13,372
14,400
14,156
15,955
16,010
15,430
16,170
15,030
14,505
14,678
14,357
15,011
19,651
21,264
22,069
24,018
26,984
30,684
52,171
50,811
56,478
62,450
66,062
63,951
106,233
103,034
109,646
109,669
109,808
86,451
77,405
78,279
54,614
56,502
63,130
50,306
60,995
54,622
55,686
54,104
52,958
45,879
46,455
45,551
46,013
46,087
44,276
46,306
48,074
46,393
51,651
53,997
55,951
57,434
73,776
76,960
80,612
90,529
86,031
92,552
93,910
93,91092,55286,03190,52980,61276,96073,77657,43455,95153,99751,65146,39348,07446,30644,27646,08746,01345,55146,45545,87952,95854,10455,68654,62260,99550,30663,13056,50254,61478,27977,40586,451109,808109,669109,646103,034106,23363,95166,06262,45056,47850,81152,17130,68426,98424,01822,06921,26419,65115,01114,35714,67814,50515,03016,17015,43016,01015,95514,15614,40013,37211,94013,45716,27715,74217,17718,90120,10517,78017,70719,30922,24024,52627,69422,14024,61928,37831,58131,15031,39333,219
   > Total Current Assets 
25,179
23,555
22,487
25,315
22,147
18,007
15,346
21,511
18,058
15,458
13,181
12,262
11,837
13,810
12,664
11,979
10,614
11,457
9,357
8,624
9,938
10,862
10,725
12,616
12,631
11,801
12,599
11,425
10,955
11,592
11,450
12,258
16,535
18,227
19,340
21,622
24,934
28,862
44,505
44,651
51,609
54,376
58,636
51,632
47,150
45,921
48,778
50,033
52,006
49,991
52,169
64,073
40,329
44,260
53,854
38,103
28,654
21,937
22,935
18,861
18,510
15,966
17,230
16,997
17,423
18,137
20,129
22,358
24,289
24,610
29,327
31,838
34,113
36,204
38,161
41,629
45,250
51,762
48,273
53,601
54,959
54,95953,60148,27351,76245,25041,62938,16136,20434,11331,83829,32724,61024,28922,35820,12918,13717,42316,99717,23015,96618,51018,86122,93521,93728,65438,10353,85444,26040,32964,07352,16949,99152,00650,03348,77845,92147,15051,63258,63654,37651,60944,65144,50528,86224,93421,62219,34018,22716,53512,25811,45011,59210,95511,42512,59911,80112,63112,61610,72510,8629,9388,6249,35711,45710,61411,97912,66413,81011,83712,26213,18115,45818,05821,51115,34618,00722,14725,31522,48723,55525,179
       Cash And Cash Equivalents 
23,076
19,148
15,945
22,509
21,151
16,961
14,307
20,475
17,485
15,202
12,935
11,823
11,413
12,143
11,068
9,978
9,679
9,708
8,119
7,209
8,298
8,740
8,601
8,948
9,781
10,213
10,326
9,411
8,852
8,899
9,438
10,136
14,161
15,322
15,925
16,235
16,894
19,422
22,708
31,209
37,217
42,628
45,338
37,127
29,654
28,058
27,182
28,802
30,785
30,600
34,486
33,700
19,663
24,342
28,241
27,995
12,639
10,034
10,357
7,924
9,249
6,351
6,346
8,840
8,688
4,731
9,142
13,283
16,071
15,628
20,548
21,850
24,191
27,477
28,836
33,427
36,338
42,086
39,825
41,981
47,984
47,98441,98139,82542,08636,33833,42728,83627,47724,19121,85020,54815,62816,07113,2839,1424,7318,6888,8406,3466,3519,2497,92410,35710,03412,63927,99528,24124,34219,66333,70034,48630,60030,78528,80227,18228,05829,65437,12745,33842,62837,21731,20922,70819,42216,89416,23515,92515,32214,16110,1369,4388,8998,8529,41110,32610,2139,7818,9488,6018,7408,2987,2098,1199,7089,6799,97811,06812,14311,41311,82312,93515,20217,48520,47514,30716,96121,15122,50915,94519,14823,076
       Net Receivables 
2,001
4,277
5,775
2,709
940
1,008
1,023
978
505
208
219
420
339
1,583
1,539
1,982
844
1,686
925
1,189
1,393
1,996
1,688
3,336
2,705
1,497
1,808
1,638
1,889
2,606
1,745
1,941
2,301
2,801
3,202
5,250
7,662
8,938
21,138
12,895
13,780
11,039
12,332
13,228
13,401
13,680
16,303
15,573
17,523
15,872
14,644
15,175
17,821
17,400
23,606
8,003
14,164
9,648
10,470
9,099
7,832
8,176
8,878
6,982
7,211
11,741
9,220
7,550
6,328
6,939
6,658
7,804
7,334
6,218
6,802
5,487
5,824
6,701
5,088
8,433
3,776
3,7768,4335,0886,7015,8245,4876,8026,2187,3347,8046,6586,9396,3287,5509,22011,7417,2116,9828,8788,1767,8329,09910,4709,64814,1648,00323,60617,40017,82115,17514,64415,87217,52315,57316,30313,68013,40113,22812,33211,03913,78012,89521,1388,9387,6625,2503,2022,8012,3011,9411,7452,6061,8891,6381,8081,4972,7053,3361,6881,9961,3931,1899251,6868441,9821,5391,5833394202192085059781,0231,0089402,7095,7754,2772,001
       Other Current Assets 
101
130
768
97
56
38
16
58
67
48
27
19
85
84
56
735
733
620
812
814
900
856
1,195
333
144
90
466
376
215
86
267
182
74
104
214
137
67
194
367
229
213
376
759
929
2,667
3,075
4,045
3,822
2,234
1,728
1,767
14,542
1,946
1,818
1,519
1,182
1,027
1,189
1,336
1,268
817
892
963
546
471
723
875
706
533
640
471
312
339
240
371
332
224
447
378
419
301
3014193784472243323712403393124716405337068757234715469638928171,2681,3361,1891,0271,1821,5191,8181,94614,5421,7671,7282,2343,8224,0453,0752,667929759376213229367194671372141047418226786215376466901443331,195856900814812620733735568485192748675816385697768130101
   > Long-term Assets 
8,040
7,838
8,662
6,266
6,231
6,612
6,794
6,183
6,468
6,782
6,128
5,446
5,944
6,294
6,238
5,198
5,128
4,821
4,100
3,317
3,433
3,538
3,431
3,339
3,379
3,630
3,571
3,605
3,550
3,086
2,908
2,753
3,116
3,037
2,729
2,396
2,050
1,822
7,666
6,161
4,869
8,074
7,426
12,319
59,083
57,113
60,868
59,636
57,802
36,460
25,236
14,206
14,285
12,242
9,276
12,203
32,341
33,185
32,751
35,243
34,448
29,913
29,225
28,554
28,590
27,950
24,147
23,948
23,785
21,783
22,324
22,159
21,838
21,230
35,615
35,331
35,362
38,767
37,758
38,951
38,951
38,95138,95137,75838,76735,36235,33135,61521,23021,83822,15922,32421,78323,78523,94824,14727,95028,59028,55429,22529,91334,44835,24332,75133,18532,34112,2039,27612,24214,28514,20625,23636,46057,80259,63660,86857,11359,08312,3197,4268,0744,8696,1617,6661,8222,0502,3962,7293,0373,1162,7532,9083,0863,5503,6053,5713,6303,3793,3393,4313,5383,4333,3174,1004,8215,1285,1986,2386,2945,9445,4466,1286,7826,4686,1836,7946,6126,2316,2668,6627,8388,040
       Property Plant Equipment 
3,093
2,972
3,519
57
58
63
74
77
76
87
85
87
203
212
210
186
173
153
121
101
99
93
82
72
68
60
50
42
36
32
24
28
24
21
25
25
20
20
23
20
24
21
22
35
205
315
286
695
857
863
790
636
314
297
266
240
229
324
690
2,677
2,475
2,306
2,198
2,097
2,035
1,966
1,907
1,844
1,781
6
501
484
445
505
481
471
441
412
402
377
369
36937740241244147148150544548450161,7811,8441,9071,9662,0352,0972,1982,3062,4752,6776903242292402662973146367908638576952863152053522212420232020252521242824323642506068728293991011211531731862102122038785877677746358573,5192,9723,093
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,730
6,730
6,112
6,112
6,112
3,835
0
0
0
0
0
0
15,706
15,706
15,706
15,706
15,706
15,706
15,706
15,706
15,706
15,706
15,706
15,706
15,706
15,706
15,706
15,706
15,706
15,706
15,706
15,706
15,706
15,706
15,706
15,706
15,706
15,70615,70615,70615,70615,70615,70615,70615,70615,70615,70615,70615,70615,70615,70615,70615,70615,70615,70615,70615,70615,70615,70615,70615,70615,7060000003,8356,1126,1126,1126,7306,73000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
4,339
4,284
4,533
4,742
4,637
4,348
4,283
4,007
3,390
3,215
3,334
3,446
3,349
3,268
3,311
3,569
3,521
3,563
3,514
3,054
2,883
2,725
3,092
3,015
2,704
2,372
2,030
1,802
1,486
1,259
1,128
908
1,472
7,902
48,050
46,753
46,114
44,635
43,099
24,355
17,582
6,436
6,374
5,601
5,400
8,384
13,460
14,305
14,130
13,933
13,721
9,998
10,378
10,139
9,913
9,686
4,178
4,045
3,913
3,780
3,647
3,514
3,381
3,068
2,754
2,451
2,126
1,885
1,763
1,503
1,244
1,2441,5031,7631,8852,1262,4512,7543,0683,3813,5143,6473,7803,9134,0454,1789,6869,91310,13910,3789,99813,72113,93314,13014,30513,4608,3845,4005,6016,3746,43617,58224,35543,09944,63546,11446,75348,0507,9021,4729081,1281,2591,4861,8022,0302,3722,7043,0153,0922,7252,8833,0543,5143,5633,5213,5693,3113,2683,3493,4463,3343,2153,3904,0074,2834,3484,6374,7424,5334,2844,3390000000000
       Long-term Assets Other 
4,947
4,866
5,144
6,209
6,173
6,549
6,719
6,106
6,392
6,695
1,704
1,075
1,208
1,341
1,390
665
672
660
589
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,700
1,700
0
0
0
0
0
975
920
844
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000844920975000001,7001,7000000000000000000000000000000000005896606726651,3901,3411,2081,0751,7046,6956,3926,1066,7196,5496,1736,2095,1444,8664,947
> Total Liabilities 
3,630
6,083
29,237
1,604
3,072
1,264
2,977
2,022
1,923
1,384
896
433
877
2,868
3,071
2,882
2,898
3,625
2,752
2,111
3,215
3,698
3,682
5,582
5,135
4,482
4,698
4,312
4,171
5,137
5,053
5,276
9,810
10,236
9,599
10,248
10,578
10,421
15,771
11,783
10,796
10,040
12,017
11,130
53,317
51,433
55,389
57,106
59,719
57,058
59,391
63,074
38,525
37,460
40,194
28,022
36,310
28,999
30,927
28,466
25,871
21,023
18,444
14,845
14,842
13,282
11,634
12,378
11,709
9,547
12,754
13,649
14,036
12,988
9,696
9,819
10,412
12,981
5,511
6,958
5,114
5,1146,9585,51112,98110,4129,8199,69612,98814,03613,64912,7549,54711,70912,37811,63413,28214,84214,84518,44421,02325,87128,46630,92728,99936,31028,02240,19437,46038,52563,07459,39157,05859,71957,10655,38951,43353,31711,13012,01710,04010,79611,78315,77110,42110,57810,2489,59910,2369,8105,2765,0535,1374,1714,3124,6984,4825,1355,5823,6823,6983,2152,1112,7523,6252,8982,8823,0712,8688774338961,3841,9232,0222,9771,2643,0721,60429,2376,0833,630
   > Total Current Liabilities 
2,508
5,001
3,827
1,604
3,072
1,264
2,977
2,022
1,923
1,384
896
433
877
1,517
1,867
1,868
2,020
2,468
1,935
1,459
2,382
3,112
3,367
3,912
3,974
3,386
3,007
2,728
2,552
3,480
2,771
3,094
4,350
5,210
5,227
6,562
7,527
7,890
13,785
10,391
9,888
9,529
11,011
10,396
48,760
14,760
18,520
19,772
21,652
19,314
20,948
42,644
17,160
16,187
27,197
17,333
22,616
17,261
21,277
18,224
17,417
16,734
16,615
13,213
13,157
11,603
9,917
10,664
10,023
9,547
12,294
13,182
13,584
12,636
9,369
9,517
10,130
12,729
5,252
6,730
4,914
4,9146,7305,25212,72910,1309,5179,36912,63613,58413,18212,2949,54710,02310,6649,91711,60313,15713,21316,61516,73417,41718,22421,27717,26122,61617,33327,19716,18717,16042,64420,94819,31421,65219,77218,52014,76048,76010,39611,0119,5299,88810,39113,7857,8907,5276,5625,2275,2104,3503,0942,7713,4802,5522,7283,0073,3863,9743,9123,3673,1122,3821,4591,9352,4682,0201,8681,8671,5178774338961,3841,9232,0222,9771,2643,0721,6043,8275,0012,508
       Short-term Debt 
516
387
0
0
0
146
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33,864
0
0
0
0
0
36,521
20,000
19,611
19,724
6,664
6,664
8,065
8,000
8,069
8,000
8,436
8,423
7,747
5,769
3,777
1,793
137
143
190
0
56
57
55
94
101
101
104
101
0
0
0
0001011041011019455575601901431371,7933,7775,7697,7478,4238,4368,0008,0698,0008,0656,6646,66419,72419,61120,00036,5210000033,86400000000000000000000000000000000000000146000387516
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36,521
39,500
19,611
19,724
6,664
6,664
8,065
8,000
8,069
8,000
8,000
8,000
7,620
5,656
3,656
1,666
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000001,6663,6565,6567,6208,0008,0008,0008,0698,0008,0656,6646,66419,72419,61139,50036,52100000000000000000000000000000000000000000000000000
       Accounts payable 
921
2,908
2,827
1,287
2,683
1,118
2,977
1,806
1,923
1,384
790
417
877
912
1,069
1,030
1,101
1,213
968
472
716
1,304
1,492
2,133
2,615
2,133
2,447
1,448
1,261
1,250
1,209
1,629
1,346
1,880
1,975
2,667
4,698
4,734
10,945
6,619
7,027
6,004
8,253
8,493
8,849
8,418
10,725
11,313
12,361
10,988
15,961
18,228
14,233
13,910
18,658
7,175
8,433
5,015
7,021
8,885
5,097
5,160
4,491
5,383
6,968
6,819
6,828
6,828
4,957
4,225
5,555
5,541
5,086
5,129
4,107
4,127
4,504
7,110
4,639
0
0
004,6397,1104,5044,1274,1075,1295,0865,5415,5554,2254,9576,8286,8286,8196,9685,3834,4915,1605,0978,8857,0215,0158,4337,17518,65813,91014,23318,22815,96110,98812,36111,31310,7258,4188,8498,4938,2536,0047,0276,61910,9454,7344,6982,6671,9751,8801,3461,6291,2091,2501,2611,4482,4472,1332,6152,1331,4921,3047164729681,2131,1011,0301,0699128774177901,3841,9231,8062,9771,1182,6831,2872,8272,908921
       Other Current Liabilities 
466
371
600
317
389
0
48
216
288
355
106
16
0
606
0
0
916
0
0
471
718
1,304
1,499
2,125
2,641
2,487
2,440
688
628
1,268
664
588
635
975
847
1,543
5,246
5,571
11,644
8,305
634
1,139
1,442
9,266
4,998
5,469
7,052
7,893
8,952
7,987
20,772
4,239
16,983
16,010
20,356
9,457
13,534
8,503
12,136
524
8,387
7,879
8,594
7,270
9,157
2,746
2,645
3,283
4,344
4,706
6,233
7,058
7,933
6,907
4,904
5,004
5,230
5,237
0
0
0
0005,2375,2305,0044,9046,9077,9337,0586,2334,7064,3443,2832,6452,7469,1577,2708,5947,8798,38752412,1368,50313,5349,45720,35616,01016,9834,23920,7727,9878,9527,8937,0525,4694,9989,2661,4421,1396348,30511,6445,5715,2461,5438479756355886641,2686286882,4402,4872,6412,1251,4991,3047184710091600606016106355288216480389317600371466
   > Long-term Liabilities 
1,122
1,082
25,410
0
0
0
0
0
0
0
0
0
0
1,351
1,204
1,013
878
1,156
817
652
833
587
314
1,670
1,161
1,096
1,692
1,585
1,619
1,658
2,282
2,182
5,461
5,026
4,372
3,687
3,051
2,531
1,985
1,392
908
511
1,006
734
4,557
36,673
36,869
37,334
38,067
37,744
38,443
20,430
21,365
21,273
12,997
10,689
13,694
11,738
9,650
10,242
8,454
4,289
1,829
1,632
1,685
1,679
1,717
1,714
1,686
0
460
467
452
352
327
302
282
252
259
228
200
20022825925228230232735245246746001,6861,7141,7171,6791,6851,6321,8294,2898,45410,2429,65011,73813,69410,68912,99721,27321,36520,43038,44337,74438,06737,33436,86936,6734,5577341,0065119081,3921,9852,5313,0513,6874,3725,0265,4612,1822,2821,6581,6191,5851,6921,0961,1611,6703145878336528171,1568781,0131,2041,351000000000025,4101,0821,122
       Long term Debt 
542
452
682
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,377
34,578
34,873
35,171
35,981
36,479
19,500
19,611
19,724
11,525
9,826
13,418
11,461
9,500
7,535
5,566
1,594
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000001,5945,5667,5359,50011,46113,4189,82611,52519,72419,61119,50036,47935,98135,17134,87334,57834,377000000000000000000000000000000000000000000682452542
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,113
1,948
1,739
1,783
1,794
1,849
1,841
1,876
0
516
524
507
446
428
403
386
353
353
323
296
29632335335338640342844650752451601,8761,8411,8491,7941,7831,7391,9483,1130000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,352
1,196
1,016
876
1,150
817
653
832
586
313
1,676
1,150
1,099
1,697
1,587
1,628
1,638
2,285
2,197
5,462
5,036
4,383
3,689
3,058
2,532
1,990
1,393
908
509
1,005
734
4,557
2,296
2,291
2,461
2,896
1,763
1,964
930
1,754
1,549
1,472
863
276
277
19
7
4
5
8
6
23
12
5
16
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000165122368547192772768631,4721,5491,7549301,9641,7632,8962,4612,2912,2964,5577341,0055099081,3931,9902,5323,0583,6894,3835,0365,4622,1972,2851,6381,6281,5871,6971,0991,1501,6763135868326538171,1508761,0161,1961,3520000000000000
> Total Stockholder Equity
29,588
25,310
1,913
29,977
25,306
23,354
19,162
25,672
22,603
20,856
18,414
17,274
16,903
17,237
15,831
14,295
12,843
12,653
10,705
9,830
10,157
10,702
10,475
10,374
10,875
10,948
11,472
10,718
10,333
9,540
9,305
9,735
9,841
11,028
12,470
13,770
16,406
20,263
36,400
39,028
45,682
52,410
54,045
52,821
52,916
51,601
54,257
52,563
50,089
29,393
18,014
15,205
16,089
19,042
22,936
22,284
24,685
25,623
24,759
25,638
27,087
24,856
28,011
30,706
31,171
32,805
32,642
33,928
36,365
36,846
38,897
40,348
41,915
44,446
64,080
67,141
70,200
77,548
80,520
85,594
88,796
88,79685,59480,52077,54870,20067,14164,08044,44641,91540,34838,89736,84636,36533,92832,64232,80531,17130,70628,01124,85627,08725,63824,75925,62324,68522,28422,93619,04216,08915,20518,01429,39350,08952,56354,25751,60152,91652,82154,04552,41045,68239,02836,40020,26316,40613,77012,47011,0289,8419,7359,3059,54010,33310,71811,47210,94810,87510,37410,47510,70210,1579,83010,70512,65312,84314,29515,83117,23716,90317,27418,41420,85622,60325,67219,16223,35425,30629,9771,91325,31029,588
   Common Stock
29,315
28,803
30,627
31,964
31,541
33,228
33,262
42,657
44,657
44,717
42,792
43,128
47,281
50,376
50,113
48,678
48,916
46,922
41,049
39,610
42,955
46,715
47,479
49,190
46,944
48,564
50,127
51,512
51,969
47,741
49,203
50,677
49,419
51,200
50,735
49,542
8,858
9,228
10,069
10,188
11,844
12,467
12,234
12,089
14,589
14,759
14,947
15,541
15,676
16,129
16,192
17,311
17,706
17,929
18,020
18,189
18,241
18,281
18,324
18,569
18,589
18,664
18,677
18,727
18,738
18,733
18,702
18,674
18,462
18,385
18,121
17,905
17,730
17,698
17,719
18,294
18,281
18,486
0
0
0
00018,48618,28118,29417,71917,69817,73017,90518,12118,38518,46218,67418,70218,73318,73818,72718,67718,66418,58918,56918,32418,28118,24118,18918,02017,92917,70617,31116,19216,12915,67615,54114,94714,75914,58912,08912,23412,46711,84410,18810,0699,2288,85849,54250,73551,20049,41950,67749,20347,74151,96951,51250,12748,56446,94449,19047,47946,71542,95539,61041,04946,92248,91648,67850,11350,37647,28143,12842,79244,71744,65742,65733,26233,22831,54131,96430,62728,80329,315
   Retained Earnings 
-22,572
-25,992
-28,736
-26,898
-30,881
-35,874
-40,292
-42,847
-49,223
-50,937
-50,496
-52,490
-58,836
-64,143
-65,943
-64,493
-66,994
-64,248
-56,313
-54,890
-60,376
-66,060
-68,043
-70,394
-67,372
-69,080
-71,181
-74,573
-75,359
-70,554
-72,188
-73,748
-72,135
-73,777
-71,530
-68,464
4,336
7,682
23,448
26,084
31,248
37,623
39,297
38,433
44,637
42,421
44,461
41,767
38,396
16,608
5,312
1,981
3,157
5,896
9,715
8,881
11,009
11,710
10,625
11,441
12,835
10,757
13,867
16,508
16,919
18,509
18,399
19,722
22,335
22,899
25,198
26,886
28,538
30,999
50,517
53,088
55,962
62,879
66,267
71,030
74,025
74,02571,03066,26762,87955,96253,08850,51730,99928,53826,88625,19822,89922,33519,72218,39918,50916,91916,50813,86710,75712,83511,44110,62511,71011,0098,8819,7155,8963,1571,9815,31216,60838,39641,76744,46142,42144,63738,43339,29737,62331,24826,08423,4487,6824,336-68,464-71,530-73,777-72,135-73,748-72,188-70,554-75,359-74,573-71,181-69,080-67,372-70,394-68,043-66,060-60,376-54,890-56,313-64,248-66,994-64,493-65,943-64,143-58,836-52,490-50,496-50,937-49,223-42,847-40,292-35,874-30,881-26,898-28,736-25,992-22,572
   Accumulated Other Comprehensive Income 
22,879
22,503
0
24,922
24,634
25,982
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
-9,514
0
0
0
000-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,514-9,5140000000000000000000000000000000000000025,98224,63424,922022,50322,879
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue21,162
Cost of Revenue-4,069
Gross Profit17,09317,093
 
Operating Income (+$)
Gross Profit17,093
Operating Expense-11,129
Operating Income10,0335,964
 
Operating Expense (+$)
Research Development440
Selling General Administrative5,393
Selling And Marketing Expenses0
Operating Expense11,1295,833
 
Net Interest Income (+$)
Interest Income1,870
Interest Expense-0
Other Finance Cost-0
Net Interest Income1,870
 
Pretax Income (+$)
Operating Income10,033
Net Interest Income1,870
Other Non-Operating Income Expenses0
Income Before Tax (EBT)12,6819,255
EBIT - interestExpense = 0
20,383
20,383
Interest Expense0
Earnings Before Interest and Taxes (EBIT)012,681
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax12,681
Tax Provision--7,702
Net Income From Continuing Ops20,38320,383
Net Income20,383
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net778-1,870
 

Technical Analysis of Cipher Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cipher Pharmaceuticals Inc. The general trend of Cipher Pharmaceuticals Inc is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cipher Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cipher Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 13.28 < 14.60.

The bearish price targets are: 8.94 > 8 > 7.45.

Tweet this
Cipher Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cipher Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cipher Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cipher Pharmaceuticals Inc. The current macd is -0.29516315.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cipher Pharmaceuticals Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Cipher Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Cipher Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Cipher Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartCipher Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cipher Pharmaceuticals Inc. The current adx is 20.99.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Cipher Pharmaceuticals Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Cipher Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cipher Pharmaceuticals Inc. The current sar is 9.2990525.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Cipher Pharmaceuticals Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cipher Pharmaceuticals Inc. The current rsi is 45.07. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Cipher Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartCipher Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cipher Pharmaceuticals Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cipher Pharmaceuticals Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Cipher Pharmaceuticals Inc Daily Stochastic Oscillator ChartCipher Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cipher Pharmaceuticals Inc. The current cci is -5.42043085.

Cipher Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartCipher Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cipher Pharmaceuticals Inc. The current cmo is -6.4326162.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Cipher Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartCipher Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cipher Pharmaceuticals Inc. The current willr is -39.06976744.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Cipher Pharmaceuticals Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Cipher Pharmaceuticals Inc Daily Williams %R ChartCipher Pharmaceuticals Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cipher Pharmaceuticals Inc. The current atr is 0.50380623.

Cipher Pharmaceuticals Inc Daily Average True Range (ATR) ChartCipher Pharmaceuticals Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cipher Pharmaceuticals Inc. The current obv is 393,593.

Cipher Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartCipher Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cipher Pharmaceuticals Inc. The current mfi is 32.74.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Cipher Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartCipher Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cipher Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-31ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-01STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-12STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-29BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-27STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-16MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-18MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Cipher Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cipher Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.069
Ma 20Greater thanMa 5010.356
Ma 50Greater thanMa 10011.105
Ma 100Greater thanMa 20010.439
OpenGreater thanClose10.590
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Cipher Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Cipher Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cipher Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cipher Pharmaceuticals Inc

I send you an email if I find something interesting about Cipher Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Cipher Pharmaceuticals Inc.

Receive notifications about Cipher Pharmaceuticals Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.